Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119370214 | 11937021 | 4 | F | 2011 | 20160920 | 20160121 | 20160926 | EXP | US-DSJP-DSU-2015-120153 | DAIICHI | 0.00 | Y | 0.00000 | 20160926 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119370214 | 11937021 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | Y | 21286 | 40 | MG | TABLET | QD | ||||||
| 119370214 | 11937021 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 20 MG, QD | Y | 21286 | 20 | MG | TABLET | QD | |||||
| 119370214 | 11937021 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/25MG, QD | 1001 | DF | Y | 0 | 1 | DF | FILM-COATED TABLET | QD | |||
| 119370214 | 11937021 | 4 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/12.5MG, QD | 1001 | DF | Y | 0 | 1 | DF | FILM-COATED TABLET | QD | |||
| 119370214 | 11937021 | 5 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | UNK | 1001 | DF | Y | 0 | FILM-COATED TABLET | |||||||
| 119370214 | 11937021 | 6 | SS | TRIBENZOR | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/5/12.5MG, QD | U | 0 | 1 | DF | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119370214 | 11937021 | 1 | Hypertension |
| 119370214 | 11937021 | 3 | Hypertension |
| 119370214 | 11937021 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119370214 | 11937021 | OT |
| 119370214 | 11937021 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119370214 | 11937021 | Acute kidney injury | |
| 119370214 | 11937021 | Adenoma benign | |
| 119370214 | 11937021 | Bowel movement irregularity | |
| 119370214 | 11937021 | Cholecystitis chronic | |
| 119370214 | 11937021 | Cholesterosis | |
| 119370214 | 11937021 | Depression | |
| 119370214 | 11937021 | Diverticulum intestinal | |
| 119370214 | 11937021 | Gallbladder polyp | |
| 119370214 | 11937021 | Gastric ulcer | |
| 119370214 | 11937021 | Gastroduodenitis | |
| 119370214 | 11937021 | Gastrointestinal sounds abnormal | |
| 119370214 | 11937021 | Gastrointestinal stromal tumour | |
| 119370214 | 11937021 | Gastrooesophageal reflux disease | |
| 119370214 | 11937021 | Hiatus hernia | |
| 119370214 | 11937021 | Ileus | |
| 119370214 | 11937021 | Intestinal metaplasia | |
| 119370214 | 11937021 | Liver function test abnormal | |
| 119370214 | 11937021 | Malabsorption | |
| 119370214 | 11937021 | Pancytopenia | |
| 119370214 | 11937021 | Reactive gastropathy | |
| 119370214 | 11937021 | Renal disorder | |
| 119370214 | 11937021 | Small intestinal obstruction | |
| 119370214 | 11937021 | Ureteral disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119370214 | 11937021 | 1 | 2013 | 201310 | 0 | |
| 119370214 | 11937021 | 2 | 201310 | 0 | ||
| 119370214 | 11937021 | 3 | 20101207 | 20130902 | 0 | |
| 119370214 | 11937021 | 4 | 20101207 | 0 | ||
| 119370214 | 11937021 | 5 | 2006 | 0 | ||
| 119370214 | 11937021 | 6 | 20150407 | 0 |